These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 26630653)

  • 21. Health-related quality of life in patients with uveitis.
    Shamdas M; Bassilious K; Murray PI
    Br J Ophthalmol; 2019 Sep; 103(9):1284-1288. PubMed ID: 30361275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Axial length as a factor associated with visual outcome after vitrectomy for diabetic macular edema.
    Wakabayashi Y; Kimura K; Muramatsu D; Usui Y; Umazume K; Suzuki J; Goto H
    Invest Ophthalmol Vis Sci; 2013 Oct; 54(10):6834-40. PubMed ID: 24052638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is utility-based quality of life in adults affected by glaucoma?
    Gothwal VK; Bagga DK; Rao HL; Bharani S; Sumalini R; Garudadri CS; Senthil S; Reddy SP; Pathak-Ray V; Mandal AK
    Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1361-9. PubMed ID: 24519425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of age-related macular degeneration on health status utility values.
    Espallargues M; Czoski-Murray CJ; Bansback NJ; Carlton J; Lewis GM; Hughes LA; Brand CS; Brazier JE
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4016-23. PubMed ID: 16249475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Correlation of retinal sensitivity, visual acuity and central macular thickness in different types of diabetic macular edema].
    Yang XL; Zou HD; Xu X
    Zhonghua Yan Ke Za Zhi; 2013 Dec; 49(12):1081-8. PubMed ID: 24499694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vision-related quality of life and visual function following vitrectomy for proliferative diabetic retinopathy.
    Okamoto F; Okamoto Y; Fukuda S; Hiraoka T; Oshika T
    Am J Ophthalmol; 2008 Jun; 145(6):1031-1036. PubMed ID: 18400203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A community-based study for the utility values associated with diabetic retinopathy among type 2 diabetics in Kinmen, Taiwan.
    Tung TH; Chen SJ; Lee FL; Liu JH; Lin CH; Chou P
    Diabetes Res Clin Pract; 2005 Jun; 68(3):265-73. PubMed ID: 15936470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of quality of life among Taiwanese patients with visual impairment.
    Lin JC; Yu JH
    J Formos Med Assoc; 2012 Oct; 111(10):572-9. PubMed ID: 23089693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing the impact of visual acuity on quality of life in individuals with type 2 diabetes using the short form-36.
    Clarke PM; Simon J; Cull CA; Holman RR
    Diabetes Care; 2006 Jul; 29(7):1506-11. PubMed ID: 16801570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Posterior sub-Tenon's capsule injection of triamcinolone acetonide prevents panretinal photocoagulation-induced visual dysfunction in patients with severe diabetic retinopathy and good vision.
    Shimura M; Yasuda K; Shiono T
    Ophthalmology; 2006 Mar; 113(3):381-7. PubMed ID: 16458970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. QALY weights for diabetic retinopathy--a comparison of health state valuations with HUI-3, EQ-5D, EQ-VAS, and TTO.
    Heintz E; Wiréhn AB; Peebo BB; Rosenqvist U; Levin LÅ
    Value Health; 2012 May; 15(3):475-84. PubMed ID: 22583458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validity of the time trade-off and standard gamble methods of utility assessment in retinal patients.
    Sharma S; Brown GC; Brown MM; Hollands H; Robins R; Shah GK
    Br J Ophthalmol; 2002 May; 86(5):493-6. PubMed ID: 11973240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of diabetic retinopathy and diabetic macular edema on health-related quality of life in type 1 and type 2 diabetes.
    Fenwick EK; Xie J; Ratcliffe J; Pesudovs K; Finger RP; Wong TY; Lamoureux EL
    Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):677-84. PubMed ID: 22205611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of Diabetic Retinopathy on Health-related Quality of Life in Iranian Diabetics.
    Alinia C; Mohammadi SF; Lashay A; Rashidian A
    Iran J Public Health; 2017 Jan; 46(1):55-65. PubMed ID: 28451530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Time Trade-off Utility Values in Noninfectious Uveitis.
    Niemeyer KM; Gonzales JA; Doan T; Browne EN; Rao MM; Acharya NR
    Am J Ophthalmol; 2019 Dec; 208():47-55. PubMed ID: 31201795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Visual acuity measurement and ocular co-morbidity in diabetic retinopathy screening.
    Scanlon PH; Foy C; Chen FK
    Br J Ophthalmol; 2008 Jun; 92(6):775-8. PubMed ID: 18356262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of visual impairment on health-related quality of life in rural Africa.
    Briesen S; Roberts H; Finger RP
    Ophthalmic Epidemiol; 2014 Oct; 21(5):297-306. PubMed ID: 25133670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of Health State Utility Measures in Patients With Head and Neck Cancer.
    Noel CW; Lee DJ; Kong Q; Xu W; Simpson C; Brown D; Gilbert RW; Gullane PJ; Irish JC; Huang SH; O'Sullivan B; Goldstein DP; de Almeida JR
    JAMA Otolaryngol Head Neck Surg; 2015 Aug; 141(8):696-703. PubMed ID: 26204439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality of life of the most severely vision-impaired.
    Crewe JM; Morlet N; Morgan WH; Spilsbury K; Mukhtar A; Clark A; Ng JQ; Crowley M; Semmens JB
    Clin Exp Ophthalmol; 2011; 39(4):336-43. PubMed ID: 21070550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.
    Haritoglou C; Kook D; Neubauer A; Wolf A; Priglinger S; Strauss R; Gandorfer A; Ulbig M; Kampik A
    Retina; 2006; 26(9):999-1005. PubMed ID: 17151486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.